Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapi…
$17.50-5.61%
报价 2026-11-13
市值
$3.24B
EV
$5.78B
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -51.8%
$16.65$36.28
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| LEGNLegend Biotech Corporation | $3.24B | -5.6% | +39.1% | 55% | – | – | – | |
| ACADACADIA Pharmaceuticals Inc. | $3.24B | +3.4% | +18.4% | 90.5% | 8.6x | 19.5x | 28.4x | |
| DYNDyne Therapeutics, Inc. | $3.22B | +0.9% | +42.9% | 0% | – | – | – | |
| CELCCelcuity Inc. | $3.15B | +0.3% | +1058.3% | 0% | – | – | – | |
| TLXTelix Pharmaceuticals Limited | $3.14B | -1.4% | – | 50.8% | – | 129.6x | – | |
| IDYAIDEAYA Biosciences, Inc. | $3.08B | +1.1% | -79.1% | 99.5% | – | – | – | |
| IRONDisc Medicine, Inc. | $3.07B | -3.9% | -47.5% | 0% | – | – | – | |
| XERSXeris Biopharma Holdings, Inc. | $3.04B | +0.1% | +39.3% | 84.4% | – | 109.0x | 38.2x | |
| ADMAADMA Biologics, Inc. | $3.03B | +3.3% | +4.7% | 68.5% | 16.7x | 12.0x | 22.3x | |
| 同行中位数 | – | – | +18.4% | 59.6% | 12.7x | 64.2x | 28.4x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。